The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression.EBI
Sookmyung Women'S University
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.EBI
Wyeth-Ayerst Research
Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities.EBI
Yeungnam University
Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase.EBI
Universiti Putra Malaysia
Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors.EBI
Ewha Womans University
Conformational analysis of 5-lipoxygenase inhibitors: role of the substituents in chiral recognition and on the active conformations of the (methoxyalkyl)thiazole and methoxytetrahydropyran series.EBI
Astrazeneca
(Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.EBI
Ici Pharmaceuticals Group